Predictive value of neutrophil-to-lymphocyte ratio for long-term adverse outcomes in cirrhosis patients post-transjugular intrahepatic portosystemic shunt

Abstract The neutrophil-to-lymphocyte ratio (NLR) may predict outcomes in end-stage liver disease, but its value after transjugular intrahepatic portosystemic shunt (TIPS) is unclear. This study explored the link between NLR and long-term outcomes in decompensated cirrhosis patients post-TIPS. We re...

Full description

Saved in:
Bibliographic Details
Main Authors: Qian Zhang, Zi Xu, Li Long, Xinhua Luo, Rongpin Wang, Kangshun Zhu
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-84630-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841559602603229184
author Qian Zhang
Zi Xu
Li Long
Xinhua Luo
Rongpin Wang
Kangshun Zhu
author_facet Qian Zhang
Zi Xu
Li Long
Xinhua Luo
Rongpin Wang
Kangshun Zhu
author_sort Qian Zhang
collection DOAJ
description Abstract The neutrophil-to-lymphocyte ratio (NLR) may predict outcomes in end-stage liver disease, but its value after transjugular intrahepatic portosystemic shunt (TIPS) is unclear. This study explored the link between NLR and long-term outcomes in decompensated cirrhosis patients post-TIPS. We retrospectively analyzed 184 patients treated between January 2016 and December 2021, noting demographic data, lab results, and follow-up outcomes, including liver transplantation or death. Cox regression, adjusted for various factors, showed that NLR is an independent predictor of post-TIPS progression (HR 1.665; 95% CI 1.149–2.414; P = 0.007). Patients were divided into tertiles based on NLR. The medium tertile had a 3.51-fold increased risk of progression compared to the lowest (HR 3.510; 95% CI 1.104–11.153, P = 0.033), and the highest tertile had a 5.112-fold increase (HR 5.112; 95% CI 1.653–15.806, P = 0.005). This suggests that NLR is a valuable prognostic marker for long-term progression in these patients, highlighting the role of systemic inflammation.
format Article
id doaj-art-729633b9c595413e852f61a6d6da4037
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-729633b9c595413e852f61a6d6da40372025-01-05T12:21:41ZengNature PortfolioScientific Reports2045-23222025-01-011511910.1038/s41598-024-84630-7Predictive value of neutrophil-to-lymphocyte ratio for long-term adverse outcomes in cirrhosis patients post-transjugular intrahepatic portosystemic shuntQian Zhang0Zi Xu1Li Long2Xinhua Luo3Rongpin Wang4Kangshun Zhu5Department of Minimally Invasive Interventional Radiology, The Second Affiliated Hospital of Guangzhou Medical UniversityDepartment of Radiology, Guizhou Provincial People’ s HospitalDepartment of Infectious Diseases, Guizhou Provincial People’ s HospitalDepartment of Infectious Diseases, Guizhou Provincial People’ s HospitalDepartment of Radiology, Guizhou Provincial People’ s HospitalDepartment of Minimally Invasive Interventional Radiology, The Second Affiliated Hospital of Guangzhou Medical UniversityAbstract The neutrophil-to-lymphocyte ratio (NLR) may predict outcomes in end-stage liver disease, but its value after transjugular intrahepatic portosystemic shunt (TIPS) is unclear. This study explored the link between NLR and long-term outcomes in decompensated cirrhosis patients post-TIPS. We retrospectively analyzed 184 patients treated between January 2016 and December 2021, noting demographic data, lab results, and follow-up outcomes, including liver transplantation or death. Cox regression, adjusted for various factors, showed that NLR is an independent predictor of post-TIPS progression (HR 1.665; 95% CI 1.149–2.414; P = 0.007). Patients were divided into tertiles based on NLR. The medium tertile had a 3.51-fold increased risk of progression compared to the lowest (HR 3.510; 95% CI 1.104–11.153, P = 0.033), and the highest tertile had a 5.112-fold increase (HR 5.112; 95% CI 1.653–15.806, P = 0.005). This suggests that NLR is a valuable prognostic marker for long-term progression in these patients, highlighting the role of systemic inflammation.https://doi.org/10.1038/s41598-024-84630-7Neutrophil-to-lymphocyte ratioTransjugular intrahepatic portosystemic shuntPrognosisCirrhosisPredictive
spellingShingle Qian Zhang
Zi Xu
Li Long
Xinhua Luo
Rongpin Wang
Kangshun Zhu
Predictive value of neutrophil-to-lymphocyte ratio for long-term adverse outcomes in cirrhosis patients post-transjugular intrahepatic portosystemic shunt
Scientific Reports
Neutrophil-to-lymphocyte ratio
Transjugular intrahepatic portosystemic shunt
Prognosis
Cirrhosis
Predictive
title Predictive value of neutrophil-to-lymphocyte ratio for long-term adverse outcomes in cirrhosis patients post-transjugular intrahepatic portosystemic shunt
title_full Predictive value of neutrophil-to-lymphocyte ratio for long-term adverse outcomes in cirrhosis patients post-transjugular intrahepatic portosystemic shunt
title_fullStr Predictive value of neutrophil-to-lymphocyte ratio for long-term adverse outcomes in cirrhosis patients post-transjugular intrahepatic portosystemic shunt
title_full_unstemmed Predictive value of neutrophil-to-lymphocyte ratio for long-term adverse outcomes in cirrhosis patients post-transjugular intrahepatic portosystemic shunt
title_short Predictive value of neutrophil-to-lymphocyte ratio for long-term adverse outcomes in cirrhosis patients post-transjugular intrahepatic portosystemic shunt
title_sort predictive value of neutrophil to lymphocyte ratio for long term adverse outcomes in cirrhosis patients post transjugular intrahepatic portosystemic shunt
topic Neutrophil-to-lymphocyte ratio
Transjugular intrahepatic portosystemic shunt
Prognosis
Cirrhosis
Predictive
url https://doi.org/10.1038/s41598-024-84630-7
work_keys_str_mv AT qianzhang predictivevalueofneutrophiltolymphocyteratioforlongtermadverseoutcomesincirrhosispatientsposttransjugularintrahepaticportosystemicshunt
AT zixu predictivevalueofneutrophiltolymphocyteratioforlongtermadverseoutcomesincirrhosispatientsposttransjugularintrahepaticportosystemicshunt
AT lilong predictivevalueofneutrophiltolymphocyteratioforlongtermadverseoutcomesincirrhosispatientsposttransjugularintrahepaticportosystemicshunt
AT xinhualuo predictivevalueofneutrophiltolymphocyteratioforlongtermadverseoutcomesincirrhosispatientsposttransjugularintrahepaticportosystemicshunt
AT rongpinwang predictivevalueofneutrophiltolymphocyteratioforlongtermadverseoutcomesincirrhosispatientsposttransjugularintrahepaticportosystemicshunt
AT kangshunzhu predictivevalueofneutrophiltolymphocyteratioforlongtermadverseoutcomesincirrhosispatientsposttransjugularintrahepaticportosystemicshunt